هيبارين منخفض الوزن الجزيئي (Arabic Wikipedia)

Analysis of information sources in references of the Wikipedia article "هيبارين منخفض الوزن الجزيئي" in Arabic language version.

refsWebsite
Global rank Arabic rank
4th place
6th place
2nd place
5th place
1st place
1st place
8,738th place
low place
207th place
462nd place
low place
low place

doi.org

  • Weitz JI؛ Weitz، Jeffrey I. (1997). "Low-molecular-weight heparins". N Engl J Med. ج. 337 ع. 10: 688–98. DOI:10.1056/NEJM199709043371007. PMID:9278467.
  • Garcia DA، Baglin TP، Weitz JI، وآخرون (2012). "Parenteral anticoagulants: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines". Chest. ج. 141 ع. 2 Suppl: e24S–43S. DOI:10.1378/chest.11-2291. PMC:3278070. PMID:22315264.
  • Hull RD (2008). "Treatment of pulmonary embolism: The use of low-molecular-weight heparin in the inpatient and outpatient settings". Thrombosis and Haemostasis. ج. 99 ع. 3: 502–510. DOI:10.1160/TH07-08-0500. PMID:18327398.
  • Snow V، Qaseem A، Barry P، Hornbake ER، Rodnick JE، Tobolic T، Ireland B، Segal JB، Bass EB، Weiss KB، Green L، Owens DK (فبراير 2007). "Management of venous thromboembolism: a clinical practice guideline from the American College of Physicians and the American Academy of Family Physicians". Annals of Internal Medicine. ج. 146 ع. 3: 204–10. DOI:10.7326/0003-4819-146-3-200702060-00149. PMID:17261857.
  • Dentali (2007). "Meta-analysis: anticoagulant prophylaxis to prevent symptomatic venous thromboembolism in hospitalized medical patients". Ann Intern Med. ج. 146 ع. 4: 278–88. CiteSeerX:10.1.1.694.4563. DOI:10.7326/0003-4819-146-4-200702200-00007. PMID:17310052.
  • Montalescot G، Ellis SG، de Belder MA، Janssens L، Katz O، Pluta W، Ecollan P، Tendera M، van Boven AJ، Widimsky P، Andersen HR، Betriu A، Armstrong P، Brodie BR، Herrmann HC، Neumann FJ، Effron MB، Lu J، Barnathan ES، Topol EJ (فبراير 2010). "Enoxaparin in primary and facilitated percutaneous coronary intervention A formal prospective nonrandomized substudy of the FINESSE trial (Facilitated INtervention with Enhanced Reperfusion Speed to Stop Events)". JACC. Cardiovascular Interventions. ج. 3 ع. 2: 203–12. DOI:10.1016/j.jcin.2009.11.012. PMID:20170878.
  • Dumaine R، Borentain M، Bertel O، Bode C، Gallo R، White HD، Collet JP، Steinhubl SR، Montalescot G (ديسمبر 2007). "Intravenous low-molecular-weight heparins compared with unfractionated heparin in percutaneous coronary intervention: quantitative review of randomized trials". Archives of Internal Medicine. ج. 167 ع. 22: 2423–30. DOI:10.1001/archinte.167.22.2423. PMID:18071163.
  • Nishioka J، Goodin S (2007). "Low-molecular-weight heparin in cancer-associated thrombosis: treatment, secondary prevention, and survival". Journal of Oncology Pharmacy Practice. ج. 13 ع. 2: 85–97. DOI:10.1177/1078155207079169. PMID:17873108.
  • Lee AY، Levine MN، Baker RI، Bowden C، Kakkar AK، Prins M، Rickles FR، Julian JA، Haley S، Kovacs MJ، Gent M (يوليو 2003). "Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer". The New England Journal of Medicine. ج. 349 ع. 2: 146–53. DOI:10.1056/NEJMoa025313. PMID:12853587.
  • Garcia، DA؛ Baglin، TP؛ Weitz، JI؛ Samama، MM؛ American College of Chest، Physicians (فبراير 2012). "Parenteral anticoagulants: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines". Chest. ج. 141 ع. 2 Suppl: e24S–43S. DOI:10.1378/chest.11-2291. PMC:3278070. PMID:22315264. مؤرشف من الأصل في 2017-07-01.
  • Hetzel، Gerd R.؛ Sucker، Christoph (2005). "The heparins: All a nephrologist should know". Nephrology Dialysis Transplantation. ج. 20 ع. 10: 2036–2042. DOI:10.1093/ndt/gfi004. PMID:16030035.

elsevierhealth.com

secure.jbs.elsevierhealth.com

mp.pl

nih.gov

pubmed.ncbi.nlm.nih.gov

  • Weitz JI؛ Weitz، Jeffrey I. (1997). "Low-molecular-weight heparins". N Engl J Med. ج. 337 ع. 10: 688–98. DOI:10.1056/NEJM199709043371007. PMID:9278467.
  • Garcia DA، Baglin TP، Weitz JI، وآخرون (2012). "Parenteral anticoagulants: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines". Chest. ج. 141 ع. 2 Suppl: e24S–43S. DOI:10.1378/chest.11-2291. PMC:3278070. PMID:22315264.
  • Hull RD (2008). "Treatment of pulmonary embolism: The use of low-molecular-weight heparin in the inpatient and outpatient settings". Thrombosis and Haemostasis. ج. 99 ع. 3: 502–510. DOI:10.1160/TH07-08-0500. PMID:18327398.
  • Snow V، Qaseem A، Barry P، Hornbake ER، Rodnick JE، Tobolic T، Ireland B، Segal JB، Bass EB، Weiss KB، Green L، Owens DK (فبراير 2007). "Management of venous thromboembolism: a clinical practice guideline from the American College of Physicians and the American Academy of Family Physicians". Annals of Internal Medicine. ج. 146 ع. 3: 204–10. DOI:10.7326/0003-4819-146-3-200702060-00149. PMID:17261857.
  • Douketis JD، Moinuddin I (2008). "Prophylaxis against venous thromboembolism in hospitalized medical patients: an evidence-based and practical approach". Polskie Archiwum Medycyny Wewnętrznej. ج. 118 ع. 4: 209–215. PMID:18575420. مؤرشف من الأصل في 2011-10-15.
  • Dentali (2007). "Meta-analysis: anticoagulant prophylaxis to prevent symptomatic venous thromboembolism in hospitalized medical patients". Ann Intern Med. ج. 146 ع. 4: 278–88. CiteSeerX:10.1.1.694.4563. DOI:10.7326/0003-4819-146-4-200702200-00007. PMID:17310052.
  • Montalescot G، Ellis SG، de Belder MA، Janssens L، Katz O، Pluta W، Ecollan P، Tendera M، van Boven AJ، Widimsky P، Andersen HR، Betriu A، Armstrong P، Brodie BR، Herrmann HC، Neumann FJ، Effron MB، Lu J، Barnathan ES، Topol EJ (فبراير 2010). "Enoxaparin in primary and facilitated percutaneous coronary intervention A formal prospective nonrandomized substudy of the FINESSE trial (Facilitated INtervention with Enhanced Reperfusion Speed to Stop Events)". JACC. Cardiovascular Interventions. ج. 3 ع. 2: 203–12. DOI:10.1016/j.jcin.2009.11.012. PMID:20170878.
  • Dumaine R، Borentain M، Bertel O، Bode C، Gallo R، White HD، Collet JP، Steinhubl SR، Montalescot G (ديسمبر 2007). "Intravenous low-molecular-weight heparins compared with unfractionated heparin in percutaneous coronary intervention: quantitative review of randomized trials". Archives of Internal Medicine. ج. 167 ع. 22: 2423–30. DOI:10.1001/archinte.167.22.2423. PMID:18071163.
  • Nishioka J، Goodin S (2007). "Low-molecular-weight heparin in cancer-associated thrombosis: treatment, secondary prevention, and survival". Journal of Oncology Pharmacy Practice. ج. 13 ع. 2: 85–97. DOI:10.1177/1078155207079169. PMID:17873108.
  • Lee AY، Levine MN، Baker RI، Bowden C، Kakkar AK، Prins M، Rickles FR، Julian JA، Haley S، Kovacs MJ، Gent M (يوليو 2003). "Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer". The New England Journal of Medicine. ج. 349 ع. 2: 146–53. DOI:10.1056/NEJMoa025313. PMID:12853587.
  • Garcia، DA؛ Baglin، TP؛ Weitz، JI؛ Samama، MM؛ American College of Chest، Physicians (فبراير 2012). "Parenteral anticoagulants: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines". Chest. ج. 141 ع. 2 Suppl: e24S–43S. DOI:10.1378/chest.11-2291. PMC:3278070. PMID:22315264. مؤرشف من الأصل في 2017-07-01.
  • Nicolaides AN (يونيو 2006). "Prevention and treatment of venous thromboembolism. International Consensus Statement (guidelines according to scientific evidence)". International Angiology : A Journal of the International Union of Angiology. ج. 25 ع. 2: 101–61. PMID:16763532.
  • Hetzel، Gerd R.؛ Sucker، Christoph (2005). "The heparins: All a nephrologist should know". Nephrology Dialysis Transplantation. ج. 20 ع. 10: 2036–2042. DOI:10.1093/ndt/gfi004. PMID:16030035.

ncbi.nlm.nih.gov

psu.edu

citeseerx.ist.psu.edu

web.archive.org